<VariationArchive VariationID="446411" VariationName="NM_018124.4(RFWD3):c.204_205dup (p.Leu69fs)" VariationType="Duplication" Accession="VCV000446411" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2017-12-04" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="439867" VariationID="446411">
      <GeneList>
        <Gene Symbol="RFWD3" FullName="ring finger and WD repeat domain 3" GeneID="55159" HGNC_ID="HGNC:25539" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="74621399" stop="74666877" display_start="74621399" display_stop="74666877" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="74655296" stop="74700778" display_start="74655296" display_stop="74700778" Strand="-" />
          </Location>
          <OMIM>614151</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018124.4(RFWD3):c.204_205dup (p.Leu69fs)</Name>
      <CanonicalSPDI>NC_000016.10:74661244:GGGG:GGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="74661244" stop="74661245" display_start="74661244" display_stop="74661245" variantLength="2" positionVCF="74661244" referenceAlleleVCF="A" alternateAlleleVCF="AGG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="74695142" stop="74695143" display_start="74695142" display_stop="74695143" variantLength="2" positionVCF="74695142" referenceAlleleVCF="A" alternateAlleleVCF="AGG" />
      </Location>
      <ProteinChange>L69fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370536.1" sequenceAccession="NM_001370536" sequenceVersion="1" change="c.204_205dup">
            <Expression>NM_001370536.1:c.204_205dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357465.1" sequenceAccession="NP_001357465" sequenceVersion="1" change="p.Leu69fs">
            <Expression>NP_001357465.1:p.Leu69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370542.1" sequenceAccession="NM_001370542" sequenceVersion="1" change="c.-682_-681dup">
            <Expression>NM_001370542.1:c.-682_-681dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370543.1" sequenceAccession="NM_001370543" sequenceVersion="1" change="c.-560_-559dup">
            <Expression>NM_001370543.1:c.-560_-559dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370537.1" sequenceAccession="NM_001370537" sequenceVersion="1" change="c.-805_-804dup">
            <Expression>NM_001370537.1:c.-805_-804dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370539.1" sequenceAccession="NM_001370539" sequenceVersion="1" change="c.-428_-427dup">
            <Expression>NM_001370539.1:c.-428_-427dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370535.1" sequenceAccession="NM_001370535" sequenceVersion="1" change="c.204_205dup">
            <Expression>NM_001370535.1:c.204_205dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357464.1" sequenceAccession="NP_001357464" sequenceVersion="1" change="p.Leu69fs">
            <Expression>NP_001357464.1:p.Leu69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018124.4" sequenceAccession="NM_018124" sequenceVersion="4" change="c.204_205dup" MANESelect="true">
            <Expression>NM_018124.4:c.204_205dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060594.3" sequenceAccession="NP_060594" sequenceVersion="3" change="p.Leu69fs">
            <Expression>NP_060594.3:p.Leu69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370540.1" sequenceAccession="NM_001370540" sequenceVersion="1" change="c.-317+3376_-317+3377dup">
            <Expression>NM_001370540.1:c.-317+3376_-317+3377dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.74661247_74661248dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.74661247_74661248dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.74695145_74695146dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.74695145_74695146dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370534.1" sequenceAccession="NM_001370534" sequenceVersion="1" change="c.204_205dup">
            <Expression>NM_001370534.1:c.204_205dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357463.1" sequenceAccession="NP_001357463" sequenceVersion="1" change="p.Leu69fs">
            <Expression>NP_001357463.1:p.Leu69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA623582065" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614151.0001" DB="OMIM" />
        <XRef Type="rs" ID="1205970095" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the trace in Figure 1 of the paper by Knies et al. (2017), PubMed 28691929 to establish the HGVS expression for this allele.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018124.4(RFWD3):c.204_205dup (p.Leu69fs) AND Fanconi anemia, complementation group W" Accession="RCV000515639" Version="1">
        <ClassifiedConditionList TraitSetID="39724">
          <ClassifiedCondition DB="MedGen" ID="C4521564">Fanconi anemia, complementation group W</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-11-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018124.4(RFWD3):c.204_205dup (p.Leu69fs) AND not provided" Accession="RCV002525010" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-30" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-30" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-12-04" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">28691929</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="39724" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="38387" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia, complementation group W</ElementValue>
                <XRef ID="MONDO:0044325" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FANCW</ElementValue>
                <XRef Type="MIM" ID="617784" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <XRef ID="C4521564" DB="MedGen" />
              <XRef ID="MONDO:0044325" DB="MONDO" />
              <XRef Type="MIM" ID="617784" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1194666" SubmissionDate="2017-11-28" DateLastUpdated="2017-12-04" DateCreated="2017-12-04">
        <ClinVarSubmissionID localKey="614151.0001_FANCONI ANEMIA, COMPLEMENTATION GROUP W (1 patient)" title="RFWD3, 2-BP DUP, 205CC_FANCONI ANEMIA, COMPLEMENTATION GROUP W (1 patient)" />
        <ClinVarAccession Accession="SCV000611756" DateUpdated="2017-12-04" DateCreated="2017-12-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 12-year-old German girl (patient 1143), born of unrelated parents, with Fanconi anemia complementation group W (FANCW; 617784), Knies et al. (2017) identified compound heterozygous mutations in the RFWD3 gene: a 2-bp duplication (c.205_206dupCC, NM_018124.3), resulting in a frameshift and premature termination (Leu69ProfsTer12) in the N-terminal region, and a c.1916T-A transversion, resulting in an ile639-to-lys (I639K; 614151.0002) substitution at a highly conserved residue in the WD40 domain, which is responsible for RPA2 (179836) binding. Neither mutation was found in the 1000 Genomes Project or the ExAC database. The c.205_206dupCC mutation was predicted to result in nonsense-mediated mRNA decay and a functionally null allele, since a truncated protein was not detected in patient cells. Patient cells showed increased chromosomal breakage following exposure to mitomycin C (MMC) and additional disruptive agents, and these defects could be restored by expression of wildtype RFWD3. The specific results suggested a defect in BRCA2 (600185)-dependent homologous recombination (HR). In vitro studies of the I639K variant indicated that it had less relocalization to the nucleus and to chromatin compared to wildtype as well as impaired interaction with RPA2, resulting in impaired HR in transduced cells.</Attribute>
              <Citation>
                <ID Source="PubMed">28691929</ID>
              </Citation>
              <XRef DB="OMIM" ID="617784" Type="MIM" />
              <XRef DB="OMIM" ID="179836" Type="MIM" />
              <XRef DB="OMIM" ID="600185" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFWD3" />
          </GeneList>
          <Name>RFWD3, 2-BP DUP, 205CC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DUP, 205CC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614151.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FANCONI ANEMIA, COMPLEMENTATION GROUP W (1 patient)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5927764" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17652515|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003239057" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28691929</ID>
          </Citation>
          <Comment>In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 446411). This variant is also known as c.205_206dupCC, p.L69Pfs*12. This premature translational stop signal has been observed in individual(s) with Fanconi anemia (PMID: 28691929). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Leu69Profs*13) in the RFWD3 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in RFWD3 cause disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFWD3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.74695142_74695143insGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1194666" TraitType="Disease" MappingType="Name" MappingValue="FANCONI ANEMIA, COMPLEMENTATION GROUP W (1 patient)" MappingRef="Preferred">
        <MedGen CUI="C4521564" Name="Fanconi anemia, complementation group W" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5927764" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

